All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-ZP10479 | Anti-Siglec 8 (EML1447) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | EML1447 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP10480 | Anti-Siglec 8 (EML1447) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | EML1447 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP10481 | Anti-Siglec 8 (HEKA) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | HEKA | Humanized | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP10482 | Anti-Siglec 8 (HEKA) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | HEKA | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP10483 | Anti-Siglec 8 (2E2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2E2 | Humanized | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP10484 | Anti-Siglec 8 (2E2) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 2E2 | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP10485 | Anti-Siglec 8 (3H1) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 3H1 | Humanized | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP10486 | Anti-Siglec 8 (3H1) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 3H1 | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP10487 | Anti-Siglec 8 (7C9) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 7C9 | Humanized | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-ZP10488 | Anti-Siglec 8 (7C9) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 7C9 | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION